Global Financial Private Client’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Global Financial Private Client's GILD Position: Q2 2026 in Review
Global Financial Private Client increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $273K and bringing the position to 12,160 shares worth $1.54M. The position accounts for 0.42% of the portfolio, ranked #70.
Global Financial Private Client first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Global Financial Private Client held 12,160 shares of Gilead Sciences worth $1.54M as of Q2 2026.
- Global Financial Private Client bought 2,072 Gilead Sciences shares in Q2 2026, an estimated $273K.
- Gilead Sciences made up 0.42% of Global Financial Private Client's portfolio in Q2 2026, its #70 holding.
- Global Financial Private Client first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Global Financial Private Client's 13F filing for Q2 2026, filed 20 Jul 2026.